Qiaoling Ma

620 total citations
67 papers, 346 citations indexed

About

Qiaoling Ma is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Qiaoling Ma has authored 67 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 17 papers in Public Health, Environmental and Occupational Health and 14 papers in Genetics. Recurrent topics in Qiaoling Ma's work include Hematopoietic Stem Cell Transplantation (33 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (17 papers). Qiaoling Ma is often cited by papers focused on Hematopoietic Stem Cell Transplantation (33 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (17 papers). Qiaoling Ma collaborates with scholars based in China, United States and Australia. Qiaoling Ma's co-authors include Erlie Jiang, Weihua Zhai, Sizhou Feng, Yi He, Jialin Wei, Aiming Pang, Mingzhe Han, Rongli Zhang, Donglin Yang and Mingzhe Han and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Qiaoling Ma

54 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaoling Ma China 10 217 94 76 67 60 67 346
Weihua Zhai China 10 225 1.0× 97 1.0× 79 1.0× 67 1.0× 70 1.2× 85 364
S Kim South Korea 11 208 1.0× 35 0.4× 78 1.0× 78 1.2× 67 1.1× 30 437
Hakan Koç Türkiye 10 216 1.0× 47 0.5× 96 1.3× 56 0.8× 66 1.1× 38 369
Ryoko Yamasaki Japan 11 166 0.8× 35 0.4× 116 1.5× 37 0.6× 55 0.9× 33 314
Liangquan Geng China 11 238 1.1× 44 0.5× 107 1.4× 67 1.0× 107 1.8× 43 320
Hiroyuki Ohigashi Japan 9 136 0.6× 37 0.4× 75 1.0× 48 0.7× 103 1.7× 48 310
Darius Sairafi Sweden 11 216 1.0× 55 0.6× 82 1.1× 24 0.4× 155 2.6× 13 312
Victor Aquino United States 7 111 0.5× 117 1.2× 51 0.7× 46 0.7× 68 1.1× 21 278
Sizhou Feng China 9 102 0.5× 40 0.4× 56 0.7× 22 0.3× 45 0.8× 58 300
D I Marks United Kingdom 10 153 0.7× 85 0.9× 61 0.8× 22 0.3× 41 0.7× 15 314

Countries citing papers authored by Qiaoling Ma

Since Specialization
Citations

This map shows the geographic impact of Qiaoling Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaoling Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaoling Ma more than expected).

Fields of papers citing papers by Qiaoling Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaoling Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaoling Ma. The network helps show where Qiaoling Ma may publish in the future.

Co-authorship network of co-authors of Qiaoling Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaoling Ma. A scholar is included among the top collaborators of Qiaoling Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaoling Ma. Qiaoling Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Jiali, Xinhui Zheng, Qi Sun, et al.. (2024). Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplantation. 59(12). 1654–1666. 2 indexed citations
3.
Wang, Mingyang, Yawei Zheng, Xiaoyu Zhang, et al.. (2024). WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients. Annals of Hematology. 103(8). 2827–2836. 1 indexed citations
5.
Lin, Qingsong, Zhangjie Chen, Xin Chen, et al.. (2024). Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center. Journal of Infection and Chemotherapy. 30(7). 608–615. 4 indexed citations
7.
He, Yi, Donglin Yang, Qiaoling Ma, et al.. (2023). Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy:a Single Center Analysis in the Real World. Blood. 142(Supplement 1). 5900–5900.
8.
He, Yi, Donglin Yang, Qiaoling Ma, et al.. (2023). Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B‐ALL in CR1 with no detectable minimal residual disease. British Journal of Haematology. 202(2). 369–378. 3 indexed citations
9.
Liu, Li, Xiaolei Pei, Yi He, et al.. (2023). Intravenous-oral itraconazole versus oral posaconazole in preventing invasive fungal diseases for acute leukemia patients. SHILAP Revista de lepidopterología. 5(2). 106–110.
10.
Zhai, Weihua, Jialin Wei, Qiaoling Ma, et al.. (2023). Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS. Blood. 142(Supplement 1). 4952–4952. 1 indexed citations
11.
Chen, Xin, Rongli Zhang, Weihua Zhai, et al.. (2023). Application prospect of low-dose porcine anti-thymocyte globulin in HLA-matched sibling donor transplantation. Hematology. 28(1). 2212943–2212943. 3 indexed citations
12.
Zhai, Weihua, Aiming Pang, Donglin Yang, et al.. (2023). Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia. Blood. 142(Supplement 1). 5893–5893.
13.
Yang, Donglin, Rongli Zhang, Xin Chen, et al.. (2023). The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation. Frontiers in Oncology. 13. 1256043–1256043. 3 indexed citations
15.
16.
Huang, Yong, Mingzhe Han, Donglin Yang, et al.. (2020). Comparative Study of Mizoribine and Mycophenolate Mofetil Combined with a Calcineurin Inhibitor-Based Immunosuppressive Regimen in Patients with Alternative Donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(9). 1663–1669. 9 indexed citations
17.
He, Yi, Sudong Zhang, Zixian Liu, et al.. (2019). Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative Neoplasms. Biology of Blood and Marrow Transplantation. 26(2). 285–291. 29 indexed citations
18.
Chen, Wenping, et al.. (2018). Clinical research of rhomboid flap graft for the pilonidal disease. 7(2). 185–189. 2 indexed citations
19.
Ding, Zhe, Mingzhe Han, Qiaoling Ma, et al.. (2015). Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease. Chinese Medical Journal. 128(15). 2065–2071. 7 indexed citations
20.
Liang, Chen, Jialin Wei, Erlie Jiang, et al.. (2014). Successful treatment of a 3-year-old boy with hepatitis-associated aplastic anemia with combination of auto-umbilical cord blood transplantation and immunosuppressive therapy. Transfusion and Apheresis Science. 52(2). 211–213. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026